Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum

Elise Ng, Christopher S. Hale, Shane A. Meehan, David E. Cohen

Research output: Contribution to journalArticle

Abstract

Netherton syndrome is a rare, autosomal recessive disorder that is characterized by congenital ichthyosis, trichorrhexis invaginata, and atopic diathesis. Ichthyosis presents at birth with erythroderma and subsequently evolves into ichthyosis linearis circumflexa; hair shaft abnormalities tend to present later. The disorder is caused by loss-of-function mutations in the SPINK5 (serine protease inhibitor Kazal-type 5) gene that encodes LEKTI (lympho-epithelial Kazal-type related inhibitor), which is a protease inhibitor that counteracts epidermal proteases involved in desquamation. Use of topical medications is limited by potential for systemic absorption and toxicity in the setting of a defective skin barrier. Therapeutic options include topical glucocorticoids and retinoids, oral retinoids, and narrowband ultraviolet B phototherapy. Topical tacrolimus has been shown to be efficacious and may be used safely with careful laboratory monitoring.

Original languageEnglish (US)
JournalDermatology Online Journal
Volume20
Issue number12
StatePublished - Dec 1 2014
Externally publishedYes

Fingerprint

Netherton Syndrome
Ichthyosis
Retinoids
Exfoliative Dermatitis
Serine Proteinase Inhibitors
Phototherapy
Disease Susceptibility
Tacrolimus
Protease Inhibitors
Hair
Glucocorticoids
Peptide Hydrolases
Parturition
Skin
Mutation
Genes
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum. / Ng, Elise; Hale, Christopher S.; Meehan, Shane A.; Cohen, David E.

In: Dermatology Online Journal, Vol. 20, No. 12, 01.12.2014.

Research output: Contribution to journalArticle

Ng, Elise ; Hale, Christopher S. ; Meehan, Shane A. ; Cohen, David E. / Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum. In: Dermatology Online Journal. 2014 ; Vol. 20, No. 12.
@article{f428c3b8779640f29cd8497f6a54a72d,
title = "Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum",
abstract = "Netherton syndrome is a rare, autosomal recessive disorder that is characterized by congenital ichthyosis, trichorrhexis invaginata, and atopic diathesis. Ichthyosis presents at birth with erythroderma and subsequently evolves into ichthyosis linearis circumflexa; hair shaft abnormalities tend to present later. The disorder is caused by loss-of-function mutations in the SPINK5 (serine protease inhibitor Kazal-type 5) gene that encodes LEKTI (lympho-epithelial Kazal-type related inhibitor), which is a protease inhibitor that counteracts epidermal proteases involved in desquamation. Use of topical medications is limited by potential for systemic absorption and toxicity in the setting of a defective skin barrier. Therapeutic options include topical glucocorticoids and retinoids, oral retinoids, and narrowband ultraviolet B phototherapy. Topical tacrolimus has been shown to be efficacious and may be used safely with careful laboratory monitoring.",
author = "Elise Ng and Hale, {Christopher S.} and Meehan, {Shane A.} and Cohen, {David E.}",
year = "2014",
month = "12",
day = "1",
language = "English (US)",
volume = "20",
journal = "Dermatology Online Journal",
issn = "1087-2108",
publisher = "Department of Dermatology UC Davis",
number = "12",

}

TY - JOUR

T1 - Netherton syndrome with ichthyosis linearis circumflexa and trichorrhexis invaginatum

AU - Ng, Elise

AU - Hale, Christopher S.

AU - Meehan, Shane A.

AU - Cohen, David E.

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Netherton syndrome is a rare, autosomal recessive disorder that is characterized by congenital ichthyosis, trichorrhexis invaginata, and atopic diathesis. Ichthyosis presents at birth with erythroderma and subsequently evolves into ichthyosis linearis circumflexa; hair shaft abnormalities tend to present later. The disorder is caused by loss-of-function mutations in the SPINK5 (serine protease inhibitor Kazal-type 5) gene that encodes LEKTI (lympho-epithelial Kazal-type related inhibitor), which is a protease inhibitor that counteracts epidermal proteases involved in desquamation. Use of topical medications is limited by potential for systemic absorption and toxicity in the setting of a defective skin barrier. Therapeutic options include topical glucocorticoids and retinoids, oral retinoids, and narrowband ultraviolet B phototherapy. Topical tacrolimus has been shown to be efficacious and may be used safely with careful laboratory monitoring.

AB - Netherton syndrome is a rare, autosomal recessive disorder that is characterized by congenital ichthyosis, trichorrhexis invaginata, and atopic diathesis. Ichthyosis presents at birth with erythroderma and subsequently evolves into ichthyosis linearis circumflexa; hair shaft abnormalities tend to present later. The disorder is caused by loss-of-function mutations in the SPINK5 (serine protease inhibitor Kazal-type 5) gene that encodes LEKTI (lympho-epithelial Kazal-type related inhibitor), which is a protease inhibitor that counteracts epidermal proteases involved in desquamation. Use of topical medications is limited by potential for systemic absorption and toxicity in the setting of a defective skin barrier. Therapeutic options include topical glucocorticoids and retinoids, oral retinoids, and narrowband ultraviolet B phototherapy. Topical tacrolimus has been shown to be efficacious and may be used safely with careful laboratory monitoring.

UR - http://www.scopus.com/inward/record.url?scp=85006253416&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006253416&partnerID=8YFLogxK

M3 - Article

VL - 20

JO - Dermatology Online Journal

JF - Dermatology Online Journal

SN - 1087-2108

IS - 12

ER -